UBS Group’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8K | Sell |
2,743
-5,718
| -68% | -$41.2K | ﹤0.01% | 7142 |
|
|
2025
Q1 | $69.8K | Sell |
8,461
-7,060
| -45% | -$58.2K | ﹤0.01% | 6051 |
|
|
2024
Q4 | $618K | Buy |
15,521
+15,507
| +110,764% | +$618K | ﹤0.01% | 4562 |
|
|
2024
Q3 | $121 | Hold |
14
| – | – | ﹤0.01% | 7921 |
|
|
2024
Q2 | $127 | Sell |
14
-419
| -97% | -$3.8K | ﹤0.01% | 7963 |
|
|
2024
Q1 | $10.6K | Buy |
+433
| New | +$10.6K | ﹤0.01% | 6045 |
|
|
2023
Q4 | – | Sell |
-217
| Closed | -$4.06K | – | 8033 |
|
|
2023
Q3 | $4.06K | Buy |
217
+212
| +4,240% | +$3.96K | ﹤0.01% | 6338 |
|
|
2023
Q2 | $110 | Sell |
5
-88
| -95% | -$1.94K | ﹤0.01% | 7405 |
|
|
2023
Q1 | $2.04K | Buy |
+93
| New | +$2.04K | ﹤0.01% | 7500 |
|
|
2022
Q1 | – | Sell |
-302
| Closed | -$90K | – | 9115 |
|
|
2021
Q4 | $90K | Buy |
302
+273
| +941% | +$81.4K | ﹤0.01% | 5326 |
|
|
2021
Q3 | $11K | Buy |
29
+15
| +107% | +$5.69K | ﹤0.01% | 6714 |
|
|
2021
Q2 | $7K | Sell |
14
-131
| -90% | -$65.5K | ﹤0.01% | 7201 |
|
|
2021
Q1 | $83K | Buy |
145
+78
| +116% | +$44.6K | ﹤0.01% | 5112 |
|
|
2020
Q4 | $46K | Buy |
+67
| New | +$46K | ﹤0.01% | 5261 |
|